Literature DB >> 3422735

High postmortem levels of hypoxanthine in the vitreous humor of premature babies with respiratory distress syndrome.

O D Saugstad1, T O Rognum.   

Abstract

To test whether or not premature babies at risk for retinopathy of prematurity have elevated hypoxanthine levels in the eye, the vitreous humor of 13 premature babies who died of severe respiratory distress syndrome and lung failure, was analyzed for hypoxanthine. Their hypoxanthine level was 459 +/- 171 mumol/L (mean +/- SD) compared with 54 +/- 71 mumol/L in seven newborn babies who died suddenly (P less than .001). In 53 adults who died suddenly, the hypoxanthine concentration was 136 +/- 119 mumol/L (P less than .001 when compared with babies with respiratory distress syndrome). Babies with respiratory distress syndrome underwent a significantly longer period with arterial PO2 levels less than 40 mm Hg (5.3 kPa) and they required supplementation with 100% oxygen significantly longer than control babies. The hypoxanthine concentration was correlated with the time during which the arterial PO2 was lower than 40 mm Hg (5.3 kPa) before death, and a significant positive correlation was found (R = .59, P less than .12). The study shows that high levels of hypoxanthine are found in vitreous humor of premature babies with respiratory distress syndrome. Because hypoxanthine is a potential oxygen radical generator and premature babies might have lower levels of antioxidants than full-term babies, it is suggested that the hypoxanthine accumulation in the eyes of premature babies with respiratory distress syndrome could play a pathogenetic role in the development of retinopathy of prematurity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3422735

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  5 in total

1.  The oxygen radical disease in neonatology.

Authors:  O D Saugstad
Journal:  Indian J Pediatr       Date:  1989 Sep-Oct       Impact factor: 1.967

2.  Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo.

Authors:  M Kuroki; E E Voest; S Amano; L V Beerepoot; S Takashima; M Tolentino; R Y Kim; R M Rohan; K A Colby; K T Yeo; A P Adamis
Journal:  J Clin Invest       Date:  1996-10-01       Impact factor: 14.808

3.  Increased lipid peroxide levels and myeloperoxidase activity in the vitreous of patients suffering from proliferative diabetic retinopathy.

Authors:  A J Augustin; W Breipohl; T Böker; J Lutz; M Spitznas
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-11       Impact factor: 3.117

4.  Evaluation of bilirubin as possible protective factor in the prevention of retinopathy of prematurity.

Authors:  D D Gaton; J Gold; R Axer-Siegel; E Wielunsky; N Naor; I Nissenkorn
Journal:  Br J Ophthalmol       Date:  1991-09       Impact factor: 4.638

Review 5.  The Free Radical Diseases of Prematurity: From Cellular Mechanisms to Bedside.

Authors:  Serafina Perrone; Antonino Santacroce; Mariangela Longini; Fabrizio Proietti; Francesco Bazzini; Giuseppe Buonocore
Journal:  Oxid Med Cell Longev       Date:  2018-07-24       Impact factor: 6.543

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.